Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8153600
APP PUB NO 20070183973A1
SERIAL NO

11346464

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic and other progressively deforming spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the elasticity and bending stiffness of progressively deforming spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the potential or progressing deformity curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue. Methods and devices that use crosslinking agents for increasing the permeability of an intervertebral disc, improving fluid flux to the intervertebral disc, and increasing the biological viability of cells within the intervertebral disc are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORTHOPEUTICS GROUP LLC2284 SAVANNAH LANE LEXINGTON KY 40513

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hedman, Thomas P Lexington, US 21 1256

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation